These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16092945)

  • 1. Neurotoxicity and behavioral deficits associated with Septin 5 accumulation in dopaminergic neurons.
    Son JH; Kawamata H; Yoo MS; Kim DJ; Lee YK; Kim S; Dawson TM; Zhang H; Sulzer D; Yang L; Beal MF; Degiorgio LA; Chun HS; Baker H; Peng C
    J Neurochem; 2005 Aug; 94(4):1040-53. PubMed ID: 16092945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein.
    Lu XH; Fleming SM; Meurers B; Ackerson LC; Mortazavi F; Lo V; Hernandez D; Sulzer D; Jackson GR; Maidment NT; Chesselet MF; Yang XW
    J Neurosci; 2009 Feb; 29(7):1962-76. PubMed ID: 19228951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Septin 4, the Drosophila homologue of human CDCrel-1, is toxic for dopaminergic neurons.
    Muñoz-Soriano V; Paricio N
    Eur J Neurosci; 2007 Dec; 26(11):3150-8. PubMed ID: 18028112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgA
    Scott L; Karuppagounder SS; Neifert S; Kang BG; Wang H; Dawson VL; Dawson TM
    J Neurosci; 2022 Dec; 42(49):9263-9277. PubMed ID: 36280265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Parkin enhances nigrostriatal and motor neuron lesion in mice over-expressing human-mutated tau protein.
    Menéndez J; Rodríguez-Navarro JA; Solano RM; Casarejos MJ; Rodal I; Guerrero R; Sánchez MP; Avila J; Mena MA; de Yébenes JG
    Hum Mol Genet; 2006 Jul; 15(13):2045-58. PubMed ID: 16698879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons.
    Goldberg MS; Fleming SM; Palacino JJ; Cepeda C; Lam HA; Bhatnagar A; Meloni EG; Wu N; Ackerson LC; Klapstein GJ; Gajendiran M; Roth BL; Chesselet MF; Maidment NT; Levine MS; Shen J
    J Biol Chem; 2003 Oct; 278(44):43628-35. PubMed ID: 12930822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.
    Manfredsson FP; Burger C; Sullivan LF; Muzyczka N; Lewin AS; Mandel RJ
    Exp Neurol; 2007 Oct; 207(2):289-301. PubMed ID: 17678648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson's disease-like pathology.
    Wang C; Kang X; Zhou L; Chai Z; Wu Q; Huang R; Xu H; Hu M; Sun X; Sun S; Li J; Jiao R; Zuo P; Zheng L; Yue Z; Zhou Z
    Nat Commun; 2018 Jan; 9(1):81. PubMed ID: 29311685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin promotes proteasomal degradation of synaptotagmin IV by accelerating polyubiquitination.
    Kabayama H; Tokushige N; Takeuchi M; Kabayama M; Fukuda M; Mikoshiba K
    Mol Cell Neurosci; 2017 Apr; 80():89-99. PubMed ID: 28254618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.
    Thomas B; von Coelln R; Mandir AS; Trinkaus DB; Farah MH; Leong Lim K; Calingasan NY; Flint Beal M; Dawson VL; Dawson TM
    Neurobiol Dis; 2007 May; 26(2):312-22. PubMed ID: 17336077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
    Wakamatsu M; Iwata S; Funakoshi T; Yoshimoto M
    J Neurosci Res; 2008 Feb; 86(3):640-6. PubMed ID: 17896793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-DOPA-induced increase in TH-immunoreactive striatal neurons in parkinsonian mice: insights into regulation and function.
    Espadas I; Darmopil S; Vergaño-Vera E; Ortiz O; Oliva I; Vicario-Abejón C; Martín ED; Moratalla R
    Neurobiol Dis; 2012 Dec; 48(3):271-81. PubMed ID: 22820144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss.
    Wang HQ; Imai Y; Inoue H; Kataoka A; Iita S; Nukina N; Takahashi R
    J Neurochem; 2008 Oct; 107(1):171-85. PubMed ID: 18691389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of l-DOPA on monoamine metabolism, cell survival and glutathione production in midbrain neuronal-enriched cultures from parkin knockout and wild-type mice.
    Casarejos MJ; Solano RM; Menéndez J; Rodríguez-Navarro JA; Correa C; García de Yébenes J; Mena MA
    J Neurochem; 2005 Aug; 94(4):1005-14. PubMed ID: 16000163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation.
    Kitao Y; Imai Y; Ozawa K; Kataoka A; Ikeda T; Soda M; Nakimawa K; Kiyama H; Stern DM; Hori O; Wakamatsu K; Ito S; Itohara S; Takahashi R; Ogawa S
    Hum Mol Genet; 2007 Jan; 16(1):50-60. PubMed ID: 17116640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkin deficiency increases vulnerability to inflammation-related nigral degeneration.
    Frank-Cannon TC; Tran T; Ruhn KA; Martinez TN; Hong J; Marvin M; Hartley M; Treviño I; O'Brien DE; Casey B; Goldberg MS; Tansey MG
    J Neurosci; 2008 Oct; 28(43):10825-34. PubMed ID: 18945890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice.
    Khang R; Park C; Shin JH
    Neuroscience; 2015 May; 294():182-92. PubMed ID: 25779963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal glutamate induces retrograde excitotoxicity and neuronal degeneration of intralaminar thalamic nuclei: their potential relevance for Parkinson's disease.
    Morales I; Sabate M; Rodriguez M
    Eur J Neurosci; 2013 Jul; 38(1):2172-82. PubMed ID: 23565852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress.
    Pickrell AM; Huang CH; Kennedy SR; Ordureau A; Sideris DP; Hoekstra JG; Harper JW; Youle RJ
    Neuron; 2015 Jul; 87(2):371-81. PubMed ID: 26182419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.